Item 2.02. Results of Operations and Financial Condition.
Fourth Quarter Financial Results
On March 18, 2019, Novavax, Inc. (the "Company") issued a press release
announcing the Company's financial results for the quarter ended December 31,
2018. A copy of this press release is attached as Exhibit 99.1 to this Current
Report on Form 8-K.
The information in Items 2.02 and 9.01 of this Form 8-K (including Exhibit 99.1)
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to
the liabilities of that section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act except as expressly set forth by specific reference in such a
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
99.1 Press release, dated March 18, 2019, regarding the Company's
financial results for the quarter ended December 31, 2018.
© Edgar Online, source Glimpses